今日阅读

Nvidia ‌CEO Jensen Huang said on Friday that robotics will be South Korea's next major sector, as he arrived for his second visit in seven months.
South Korea is an Asian manufacturing powerhouse - home to major manufacturers of ​chips, electronics, cars and ships.
After landing at Gimpo International Airport on a flight from Taiwan, Huang told reporters that ​chip manufacturing will be increasingly driven by AI and robotics.
Huang said he had meetings scheduled with Hyundai Motor (005380.KS), LG (003550.KS), SK ​Hynix (000660.KS), Samsung Electronics (005930.KS) and Naver (035420.KS) during his trip.
"Because Korea is a manufacturing centre of the ⁠world, we can apply the robotics technology, the physical AI technology that we invent here for the industry," he said. "So we have ​a great opportunity to partner with the semiconductor companies here as well."
"Did I bring any gifts for Korea? I brought a lot of business for Korea," he said. "I have some surprises."
Huang has said Samsung, SK Hynix and Micron have all been qualified to supply HBM4 chips for its Vera Rubin AI platform. "All three vendors are in production, and they ​are all racing to support Vera Rubin."
"We ⁠are all booming," Huang told the crowd during the dinner, referring to his partners, such as Samsung, SK Hynix, Naver and Hyundai Motor.#JPMorganBofACitiPlanTokenizedDepositNetwork
#ZcashUnlimitedMintingFlawFound

$HYPE hit a new all time high of $70, adding $11 billion in market cap in 2026 alone. Here is exactly why it keeps going up.
The US CFTC just approved the first American perpetual futures product, the exact model Hyperliquid is built on. That approval potentially opens access to a multi-trillion-dollar market that previously had no regulated US entry point.
The platform generates between $900 million and $1 billion in real fees annually. With 11 employees. That is not a typo.
98% of those trading fees are used to buy back $HYPE and permanently remove it from circulation. Buybacks have already surpassed $2 billion, meaning the supply keeps shrinking while demand keeps growing.
On top of that, $100 million has flowed in since the ETF launched, with funds like Bitwise using their own fee revenue to buy more $HYPE.
Shrinking supply. Rising fees. Institutional inflows. Regulatory tailwinds. The fundamentals here are not complicated.

🚨It has been one of the most brutal weeks in crypto in years. Here is every major data point from the carnage.
• Bitcoin hit a new yearly low of $59,127. That single move wiped out $300 billion in market cap and sent the Fear and Greed Index to 12, one of the lowest readings in Bitcoin's history.
• Ethereum dropped to $1,500 for the first time in over a year, erasing $60 billion in value. ETH is now down over 50% from its 2026 high and has lost its ranking to Tether by market cap.
• Bitcoin ETFs recorded their second largest weekly sell-off since launch, with $1.72 billion worth of BTC dumped in a single week. Institutional money has been exiting consistently for almost a month straight.
• Over $5.7 billion in leveraged long positions were liquidated in just 7 days. That is nearly $5.7 billion of retail traders who bet the market was going up and got wiped out before the week ended.
• Michael Saylor and Tom Lee's combined unrealized losses hit $22.5 billion. Strategy sits on a $13 billion paper loss on its Bitcoin holdings. Bitmine is $10 billion underwater on Ethereum. Neither has sold.
• Zcash crashed 60% after a critical bug was discovered that had been sitting undetected inside its code for four years. Claude AI found it during a security audit. A whale who shorted ZEC before the disclosure walked away with $18 million in profit.
One week. Six historic data points. The kind of week that separates conviction holders from panic sellers.
The market has seen worse and come back harder. But this one hurt.#JPMorganBofACitiPlanTokenizedDepositNetwork
#ZcashUnlimitedMintingFlawFound
#SatoshiEraBitcoinDormantAddressMoves
#BTC $BTC $ZEC $XAU

$BTC
The bank upgraded Tesla from Underweight (Sell) to Neutral (Hold) and massively raised its price target to $475 from its previous target of $145—a stunning 228% increase.
The main driver behind this structural shift is a complete re-evaluation of Tesla as a leader in "Physical AI" (the intersection of artificial intelligence, autonomous fleets, and robotics).
J.P. Morgan analysts led by Rajat Gupta highlighted Tesla’s deep hardware-and-software vertical integration at industrial scale:
• Optimus Testing Grounds: The bank noted that Tesla using its own cell and vehicle manufacturing plants as a real-world test bed for the Optimus humanoid robot gives it a dual advantage.
• Massive TAM Expansion: JPMorgan estimates the global total addressable market (TAM) for humanoid robots could reach 30 million units by 2040 (5 million in the U.S. alone).
• Autonomous and Fleet Projections: By 2040, JPMorgan projects Tesla's personal autonomous fleet could reach 35 million vehicles, alongside a dedicated Robotaxi fleet of roughly 40 million units.
• Long-Term Revenue: Expected to more than double from roughly $95 billion in 2025 to $203 billion by 2030, with nearly half of that incremental growth driven by non-automotive services (Autonomy, Robotaxis, and Optimus).$TSLA #MyStocksQuestion

Eli Lilly’s $1 trillion valuation makes it the only pharmaceutical giant in history to join the trillion-dollar club. It cements Lilly’s status as Wall Street's ultimate weight-loss play.
The stock is up over 28% since the market’s March 30 low and more than 410% over the past five years, turning Eli Lilly into the market’s clearest bet on the next phase of the GLP-1 boom.
The core growth engine remains its powerhouse GLP-1 franchise: diabetes treatment Mounjaro and obesity drug Zepbound. Together, these two blockbusters accounted for nearly $13 billion in a single quarter, claiming massive market share in a global obesity market that analysts project could surpass $150 billion annually.
While current drugs dominate, Lilly's next-generation pipeline is keeping the multi-year growth story alive.
Retatrutide, Eli Lilly’s experimental next-generation obesity drug is not approved yet, but the data is already pulling Wall Street’s attention beyond today’s GLP-1 leaders.
The trial numbers explain the buzz. In Eli Lilly’s phase 3 TRIUMPH-1 obesity trial, patients on the highest dose lost an average of 70.3 pounds, or 28.3% of body weight, over 80 weeks. More than 45% of patients on that dose lost at least 30% of their body weight, a level Eli Lilly said has long been associated with bariatric surgery.
#MyStocksQuestion #USJobsReportDoublesForecasts

$BTC
• S&P 500 down 1.65% — $1.14 trillion wiped
• Nasdaq down 2.60% — $1.11 trillion wiped
• Gold down 3.38% — $1 trillion wiped
• Silver down 6.9% — $280 billion wiped
• Bitcoin down 6.31% — $80 billion wiped
$2.5 trillion wiped in a single session. These were not isolated moves. Everything started breaking at the same time.
It started with the jobs report. The US economy added 172,000 jobs in May. Wall Street expected 88,000. Almost double. On any normal day that is good news. But with inflation already at 3.8% and oil at $90, a labor market this strong tells the Fed it cannot cut rates and may need to raise them. The probability of a rate hike this year jumped from 40% to 57% in one day.
Then the AI trade started cracking.
Broadcom reported record earnings yesterday. Revenue up 48%. AI chip sales up 143%. The stock still crashed 12.6% because it did not raise its full year AI revenue targets. That one miss made investors ask a question they had been avoiding for months. Are we paying too much for AI?
That question got louder when research firm SemiAnalysis revealed Nvidia's next-generation chips will need roughly half the memory the market was pricing in. SK Hynix fell 10%. Samsung fell 6%. South Korea's entire market crashed 5.5%. Japan's semiconductor stocks followed.
Then Anthropic published a report warning that AI is approaching the point where it can improve itself without human help, and called for a global pause in AI development. Coming on the same day as the memory news and Broadcom's miss, it fed one growing fear across the market. What if the AI boom is moving faster than the business models can keep up with?
And underneath all of this, there is a liquidity problem nobody is talking about.
SpaceX goes public next week at a $1.75 trillion valuation. Anthropic just filed. OpenAI is next. These three companies together are worth $4 to $5 trillion. Fund managers need cash to buy in. Cash levels are already at their lowest since early 2024. The only way to raise cash is to sell what they already own. That selling is happening right now.
The new Fed Chair Kevin Warsh holds his very first policy meeting in 11 days. He was appointed by Trump with the expectation of cutting rates. He is now walking into high inflation, high oil, and a hot labor market. Nobody knows what he will do.
When nobody knows what the most powerful central banker in the world will decide in less than two weeks, the safest move is to reduce risk today.
A hot jobs report. A cracking AI trade. A trillion dollar liquidity drain. A Fed meeting with no clear outcome. Everything that could go wrong went wrong at exactly the same time.$BTC $XAU
#MyStocksQuestion #USJobsReportDoublesForecasts 9#BitcoinSlipsAfterStrongUSJobsReport #USPayrollsTripleBeat

Nvidia’s (NVDA) market cap falls below the $5 trillion mark for the first time since May 6 amid a broader semiconductor selloff and market rotation.
The stock has plunged more than 6% today, wiping out over $320 billion in market capitalization, and is on track of its worst single-day decline since April 16, 2025.
The primary catalyst for the broader semiconductor selloff was Broadcom (AVGO) reporting disappointing AI chip revenue guidance. Broadcom missed expectations by roughly $1.2 billion, causing its own stock to plunge over 20% in just 2 days.
This sparked a sudden wave of profit-taking across the entire AI ecosystem, pulling down peers like Micron, AMD, Intel and Marvell Technology alongside Nvidia.
$BTC